• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.45% Nasdaq Up0.49%

    Aoxing Pharmaceutical Company, Inc. (AXN)

    1.76 Down 0.02(1.12%) 3:04PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Aoxing Pharmaceutical Company, Inc.
    No.1, Nanhuan Eastern Road
    Xinle County
    Shijiazhuang, 050700
    China - Map
    Phone: 86 311 8519 6969
    Fax: 86 311 8519 6888
    Website: http://www.aoxingpharma.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Major
    Full Time Employees:481

    Business Summary 

    Aoxing Pharmaceutical Company, Inc., a specialty pharmaceutical company, researches, develops, manufactures, and distributes various narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People’s Republic of China. The company’s principal products comprise Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; and Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid. Its principal products under development include Tilidine hydrochloride, which is under production preparation and is intended for the treatment of severe pain and chronic cancer-related pain; Codeine Phosphate Compound oral solution that is under review phase and is intended for the treatment of cold and flu; Buprenorphine/Naloxone, which is intended for the treatment of opioid dependence; and Oxycodone and Acetaminophen tablets and compound capsules, which are clinical development to cure acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Aoxing Pharmaceutical Company, Inc.

    Key Executives 
    Mr. Zhenjiang Yue , 56
    Chief Exec. Officer and Chairman
    Mr. Wilfred Chow , 49
    Chief Financial Officer and Corp. Sec.
    Mr. Guoan Zhang , 45
    Chief Accounting Officer and Sr. VP of Fin.
    Ms. Yunlan Tang , 69
    Chief Engineer
    Ms. Guirong Zhou , 61
    Pres of R&D
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders